Taiwan clears VUNO’s AI fundus evaluation software
South Korean agency VUNO has gained the approval of Taiwan’s Meals and Drug Administration to market its AI fundus evaluation software program.
VUNO Med-Fundus AI analyses pictures of the fundus to shortly detect areas of lesions indicative of retinal ailments, together with diabetic retinopathy, macular illness and glaucoma.
This newest certification follows Taiwan FDA’s clearance for its different AI merchandise, VUNO-Med Chest X-ray and VUNO-Med Bone Age. Simply two months in the past, VUNO obtained Singapore’s clearance for VUNO Med-Fundus AI.
Research validates AIRS Medical’s AI resolution for denoising 3D MR pictures
AIRS Medical, a medical AI startup from South Korea, has not too long ago proved in a examine the potential of its AI-powered MRI reconstruction resolution, SwiftMR, to denoise and vastly enhance the standard of 3D MR pictures.
Based mostly on its findings, a deep neural network-based noise discount and picture high quality enchancment software outperformed the standard magnetisation-prepared fast gradient-echo (MP-RAGE) sequence in bettering MR picture high quality.
“We’re more than happy that we have now proved SwiftMR contributes to not solely lowering time but in addition [helping] make pictures nice, finally [helping] radiologists learn pictures with confidence,” stated AIRS Medical CEO Dr Hyeseong Lee.
Qure.ai packages options utilizing NVIDIA’s MONAI package
Indian well being expertise startup Qure.ai is likely one of the early adopters of NVIDIA’s newest open-source framework for deploying AI medical imaging purposes.
The MONAI Software Packages (MAP) simplify the method of deploying an AI mannequin in an present healthcare ecosystem.
Qure.ai is now packaging its AI options for deployment utilizing MAPs, accelerating its medical impression, in keeping with NVIDIA.
UK-based Cambridge Cognition brings mind well being options to China
London-listed Cambridge Cognition, a supplier of cognitive evaluation check options, has entered into a brand new partnership to deliver its digital well being choices to China.
The corporate not too long ago signed a 10-year unique licensing deal and strategic partnership with Luca Healthcare, an area developer of digital well being evaluation instruments.
Luca can be making Cambridge Cognition’s CANTAB suite of digital mind well being checks out there in China by way of its LucaPlex platform.
“China has over 265 million individuals aged 60 years and above, of which 40 million individuals have gentle cognitive impairment and 15 million individuals with a type of dementia. With neurodegenerative ailments, early analysis is the important thing to managing illness development. We are going to leverage Cambridge Cognition’s analysis, scientific know-how, and digital expertise to make out there superior cognitive evaluation instruments for the medical trials market and the healthcare market in China,” stated Luca CEO Echo Chen.
